|
US4434228A
(en)
|
1982-04-20 |
1984-02-28 |
Genex Corporation |
Immobilization of biological materials in condensed polyalkyleneimine polymers
|
|
EP0467349B1
(en)
|
1983-10-20 |
2000-12-27 |
The Research Foundation Of State University Of New York |
Regulation of gene expression by employing translational inhibition utilizing mRNA interfering complementary RNA
|
|
FR2573436B1
(fr)
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
|
US4816568A
(en)
|
1986-05-16 |
1989-03-28 |
International Minerals & Chemical Corp. |
Stabilization of growth hormones
|
|
FR2602790B1
(fr)
|
1986-08-13 |
1990-06-01 |
Transgene Sa |
Expression d'un antigene specifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement preventif ou curatif de la tumeur correspondante
|
|
ATE115999T1
(de)
|
1987-12-15 |
1995-01-15 |
Gene Shears Pty Ltd |
Ribozyme.
|
|
US5420105A
(en)
|
1988-09-23 |
1995-05-30 |
Gustavson; Linda M. |
Polymeric carriers for non-covalent drug conjugation
|
|
US5252713A
(en)
|
1988-09-23 |
1993-10-12 |
Neorx Corporation |
Polymeric carriers for non-covalent drug conjugation
|
|
US5744166A
(en)
*
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
|
DK0554284T3
(da)
|
1990-10-24 |
1997-01-06 |
Allelix Biopharma |
Peptid-baserede hæmmere af Hiv-replikation
|
|
US5190873A
(en)
*
|
1991-06-21 |
1993-03-02 |
California Institute Of Biological Research |
Hybrid tryptophan aporepressor containing ligand binding sites
|
|
GB9120306D0
(en)
|
1991-09-24 |
1991-11-06 |
Graham Herbert K |
Method and compositions for the treatment of cerebral palsy
|
|
US5607691A
(en)
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
|
EP0903408A3
(en)
*
|
1992-08-21 |
2005-11-02 |
Biogen, Inc. |
Tat-derived transport polypeptide
|
|
US5877278A
(en)
|
1992-09-24 |
1999-03-02 |
Chiron Corporation |
Synthesis of N-substituted oligomers
|
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
|
US6974578B1
(en)
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
US5766605A
(en)
|
1994-04-15 |
1998-06-16 |
Mount Sinai School Of Medicine Of The City University Of New York |
Treatment of autonomic nerve dysfunction with botulinum toxin
|
|
NO180167C
(no)
*
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
|
US5484720A
(en)
*
|
1994-09-08 |
1996-01-16 |
Genentech, Inc. |
Methods for calcium phosphate transfection
|
|
US6232295B1
(en)
*
|
1994-10-12 |
2001-05-15 |
Jon Faiz Kayyem |
Cell-specific contrast agent and gene delivery vehicles
|
|
US5512547A
(en)
|
1994-10-13 |
1996-04-30 |
Wisconsin Alumni Research Foundation |
Pharmaceutical composition of botulinum neurotoxin and method of preparation
|
|
US5756468A
(en)
|
1994-10-13 |
1998-05-26 |
Wisconsin Alumni Research Foundation |
Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
GB9508204D0
(en)
*
|
1995-04-21 |
1995-06-07 |
Speywood Lab Ltd |
A novel agent able to modify peripheral afferent function
|
|
GB9600272D0
(en)
|
1996-01-06 |
1996-03-06 |
Univ Nottingham |
Polymers
|
|
AU729643B2
(en)
|
1996-05-01 |
2001-02-08 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
|
GB9623051D0
(en)
|
1996-11-06 |
1997-01-08 |
Schacht Etienne H |
Delivery of DNA to target cells in biological systems
|
|
FR2755976B1
(fr)
*
|
1996-11-15 |
1999-01-15 |
Idm Immuno Designed Molecules |
Nouveaux complexes d'acides nucleiques et de polymere substitue par des residus entrainant la destabilisation des membranes cellulaires
|
|
US5794496A
(en)
|
1996-12-05 |
1998-08-18 |
Hand Tool Design Corporation |
Pawl module for ratchet wrench
|
|
CA2286590C
(en)
*
|
1997-04-18 |
2005-08-02 |
California Institute Of Technology |
Multifunctional polymeric tissue coatings
|
|
ES2210761T3
(es)
*
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
WO1999024596A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Valentis, Inc. |
Expression plasmids for multiepitope nucleic acid-based vaccines
|
|
US5985434A
(en)
|
1997-11-25 |
1999-11-16 |
Kimberly-Clark Worldwide, Inc. |
Absorbent foam
|
|
CA2314267A1
(en)
|
1997-12-10 |
1999-06-17 |
Washington University |
Anti-pathogen system and methods of use thereof
|
|
WO1999042091A2
(en)
|
1998-02-19 |
1999-08-26 |
Massachusetts Institute Of Technology |
Use of polycations as endosomolytic agents
|
|
US6011646A
(en)
*
|
1998-02-20 |
2000-01-04 |
The Regents Of The Unviersity Of California |
Method to adjust multilayer film stress induced deformation of optics
|
|
FR2777890B1
(fr)
*
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6261679B1
(en)
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
|
CN1313873A
(zh)
|
1998-07-13 |
2001-09-19 |
表达遗传学公司 |
作为可溶性,生物可降解基因送递载体的聚－l－赖氨酸的聚酯类似物
|
|
US6280937B1
(en)
*
|
1998-08-14 |
2001-08-28 |
Rigel Pharmaceuticals, Inc. |
Shuttle vectors
|
|
CA2347828A1
(en)
|
1998-10-27 |
2000-05-04 |
Mayo Foundation For Medical Education And Research |
Methods for enhancing wound healing
|
|
ES2213397T3
(es)
|
1998-12-02 |
2004-08-16 |
I.D.M. Immuno-Designed Molecules |
Nuevos conjugados oligomericos capaces de transferir moleculas biologicas a las celulas.
|
|
EP1137664A2
(en)
|
1998-12-10 |
2001-10-04 |
Washington University |
Protein transduction system and methods of use thereof
|
|
CA2354644A1
(en)
*
|
1998-12-11 |
2000-06-15 |
Biomira, Inc. |
Muc-1 antagonists and methods of treating immune disorders
|
|
US7056656B1
(en)
|
1999-01-25 |
2006-06-06 |
University Of Medicine And Dentistry Of New Jersey |
Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
|
|
ES2160485B1
(es)
|
1999-04-23 |
2002-05-16 |
Lipotec Sa |
Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
|
|
US20030236214A1
(en)
*
|
1999-06-09 |
2003-12-25 |
Wolff Jon A. |
Charge reversal of polyion complexes and treatment of peripheral occlusive disease
|
|
EP1074625A3
(en)
*
|
1999-06-14 |
2002-01-02 |
Pfizer Products Inc. |
DNA vaccine against feline immunodeficiency virus
|
|
US6492152B1
(en)
*
|
1999-06-15 |
2002-12-10 |
The Board Of Regents Of The University Of Oklahoma |
Core 1 β3-galactosyl transferases and methods of use thereof
|
|
US7008924B1
(en)
*
|
1999-07-21 |
2006-03-07 |
Amgen, Inc. |
VGF fusion polypeptides
|
|
WO2001013957A2
(en)
|
1999-08-24 |
2001-03-01 |
Cellgate, Inc. |
Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
US7229961B2
(en)
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US20030104622A1
(en)
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
|
EP1250450A2
(en)
*
|
1999-09-03 |
2002-10-23 |
University of Iowa Research Foundation Inc. |
Quorum sensing signaling in bacteria
|
|
US6610820B1
(en)
|
1999-10-12 |
2003-08-26 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US6297056B1
(en)
*
|
1999-10-12 |
2001-10-02 |
Pioneer Hi-Bred International, Inc. |
Brassica transformation via microprojectile bombardment
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6844324B1
(en)
*
|
1999-11-12 |
2005-01-18 |
Massachusetts Institute Of Technology |
Modular peptide mediated intracellular delivery system and uses therefore
|
|
US7070807B2
(en)
|
1999-12-29 |
2006-07-04 |
Mixson A James |
Branched histidine copolymers and methods for using same
|
|
US20030118598A1
(en)
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
US6670322B2
(en)
|
2000-06-01 |
2003-12-30 |
Wisconsin Alumni Research Foundation |
Method of targeting pharmaceuticals to motor neurons
|
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
|
US20040033241A1
(en)
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
EP1164796B1
(en)
*
|
2000-06-14 |
2006-12-20 |
Eads Astrium Sas |
Process and system for video on demand
|
|
DK1301213T3
(en)
|
2000-07-21 |
2017-03-27 |
Revance Therapeutics Inc |
MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT
|
|
US20040220100A1
(en)
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
US7491799B2
(en)
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US6831059B2
(en)
|
2000-10-20 |
2004-12-14 |
Allergan, Inc. |
Compositions and methods for treating gonadotrophin related illnesses
|
|
DE60233137D1
(de)
|
2001-02-16 |
2009-09-10 |
Univ R |
Transporter mit beabstandeten arginin-teilchen
|
|
US20030086256A1
(en)
|
2001-11-02 |
2003-05-08 |
Heart Linked Corporation Ltd |
Compact light weight energy-efficient illumination module for integrated portable applications
|
|
US7060498B1
(en)
|
2001-11-28 |
2006-06-13 |
Genta Salus Llc |
Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
|
|
MXPA04005611A
(es)
|
2001-12-11 |
2005-04-19 |
Cellgate Inc |
Reactivos y conjugados de transporte de guanidinio.
|
|
WO2003102166A2
(en)
|
2002-02-26 |
2003-12-11 |
Maxygen, Inc. |
Novel flavivirus antigens
|
|
US20030215395A1
(en)
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
|
US7459164B2
(en)
|
2002-05-28 |
2008-12-02 |
Botulinum Toxin Research Associates, Inc. |
Composition for therapeutic and cosmetic botulinum toxin
|
|
US20040013687A1
(en)
|
2002-05-31 |
2004-01-22 |
Thomas Jefferson University |
Compositions and methods for transepithelial molecular transport
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US7071167B2
(en)
|
2002-11-13 |
2006-07-04 |
L'oreal |
Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
|
|
US6866856B2
(en)
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
|
WO2004084805A2
(en)
|
2003-03-19 |
2004-10-07 |
The J. David Gladstone Institutes |
Acetylated tat polypeptides and methods of use thereof
|
|
WO2004084839A2
(en)
|
2003-03-24 |
2004-10-07 |
Cady Roger K |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
|
WO2004084905A2
(en)
|
2003-03-24 |
2004-10-07 |
University Of Florida |
Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
|
|
BRPI0508440A
(pt)
|
2004-03-03 |
2007-07-24 |
Revance Therapeutics Inc |
composições e métodos para diagnóstico tópico e transporte terapêutico
|
|
HUE025656T2
(en)
|
2004-03-03 |
2016-04-28 |
Revance Therapeutics Inc |
Topical application and transdermal delivery of botulinum toxins
|
|
US7691381B2
(en)
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20060040882A1
(en)
|
2004-05-04 |
2006-02-23 |
Lishan Chen |
Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
|
|
EP1786459B1
(en)
|
2004-07-26 |
2014-02-12 |
Merz Pharma GmbH & Co. KGaA |
Therapeutic composition whit a botulinum neurotoxin
|
|
US20060024331A1
(en)
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
|
KR20070110402A
(ko)
|
2005-03-03 |
2007-11-16 |
레반스 테라퓨틱스 |
보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
|